BioSig Technology

BioSig Technologies is a publicly traded medical technology company focused on signal processing and digital solutions for interventional electrophysiology. Its core product is the PURE EP Platform, a hardware and software system designed to acquire, process, and display high-fidelity intracardiac signals during catheter ablation and other EP procedures. The company operates in the cardiovascular healthcare market rather than traditional therapeutics, so its value proposition centers on improving procedural visualization, workflow, and clinical decision-making for electrophysiologists. BioSig has also described broader digital and data-driven ambitions around electrophysiology and cardiac signal intelligence, but its primary commercial identity remains tied to the PURE EP system.